4 Nov 2014 16:15
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
AKR.L Share News (AKR)
AKR Share
Price
AKR Share
News
AKR Share
Chat
AKR Share
Trades
AKR
Live RNS
AKR Share
Charts
AKR Broker
Ratings
AKR Directors
Deals
AKR Financial
Diary
AKR
Fundamentals
AKR Short
Positions
AKR
Media
AKR.L Information
- There is currently no data for AKR
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Akers Biosciences, ChubeWorkx settle lengthy legal dispute
Fri, 19th Aug 2016 12:18
(ShareCast News) - Akers Biosciences has reached a settlement agreement with former distributor ChubeWorkx Guernsey Ltd, allowing it to recover $1.25m in product and cash and end a lengthy legal dispute between the pair.ChubeWorkx would recover what it was owed from a promissory note by taking delivery of $0.75m of BreathScan alcohol detectors. It would re-sell these. ChubeWorkx would also receive $0.5m cash.Settlement of the legal dispute would allow Akers to sell its breath tests globally, having regained certain rights from ChubeWorkx, which would receive a 5% gross revenue royalty up to $5m.At 12:34 BST, shares in Akers were up 5.44% to 242.5p.
More News
4 Nov 2014 06:13
3 Nov 2014 16:09
15 Aug 2014 07:39
15 Aug 2014 06:46
17 Jul 2014 10:18
25 Jun 2014 12:10
Akers Biosciences secures US distribution for heparin test
Shares in Akers Biosciences were higher on news that it had secured a major distribution agreement in the US for its test to determine if patients will have a reaction to blood thinner heparin. The company's PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests with Medline Industries, which it said was
Read more